Posts Tagged ‘FDA’

QT Ultrasound Launches Imaging Centres

Posted on: January 18th, 2019 by admin 2 Comments

Five years ago, Delphinus announced it had received 510(k) clearance from the FDA and was able to begin marketing its whole breast […]

FDA Hit by Government Shutdown

Posted on: January 4th, 2019 by admin 1 Comment

Just north of downtown Washington, DC, in suburban Maryland, lies the sprawling campus of the Food and Drug Administration (FDA), […]

Don’t Lose the 3

Posted on: November 30th, 2018 by admin

Six years ago, the CEO of French manufacturer Poly Implant Prosthese, Jean-Claude Mas, was convicted and sent to jail for using non-medical […]

X-ray Interferometry – An Emerging Technology

Posted on: September 14th, 2018 by admin 2 Comments

For the past decade, Marco Stampanoni and his TOMCAT team at the Paul Scherrer Institut (PSI) and the Eidgenössische Technische Hochschule (ETH) […]

The Science of Sure

Posted on: August 3rd, 2018 by admin

According to the World Intellectual Property Organisation, “a patent is an exclusive right granted for an invention, which is a product […]

POCUS Gathers Momentum

Posted on: July 13th, 2018 by admin 2 Comments

In the past week two companies – Hologic from the USA and Healcerion from South Korea – have announced FDA […]

Ultrasound on a Chip

Posted on: December 1st, 2017 by admin 5 Comments

The annual meeting of the Radiological Society of North America (RSNA) came to an end in Chicago today and yet […]

Breast Imaging in DIEurope

Posted on: October 20th, 2017 by admin

Diagnostic Imaging Europe is published in both online and hardcopy formats eight times a year and distributed to 25,000 radiologists […]

ACRIN is an Acronym to Remember

Posted on: September 29th, 2017 by admin

The American College of Radiology Imaging Network – or ACRIN – is a non-profit organisation that conducts research on adults […]

Approval of “Living Drug” to Treat Cancer

Posted on: September 1st, 2017 by admin 4 Comments

In 2012 six-year-old Emily Whitehead was diagnosed with acute lymphoblastic leukaemia and, since she did not respond to standard treatment, was near […]